Restorative therapies in Parkinsons disease / by Brundin, Patrik, Olanow, C. W. (Charles Warren), 1941-

Subjects:

Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson’s Disease by Nitu Kumari, Santosh Anand, Kamal Shah, Nagendra Singh Chauhan, Neeraj K. Sethiya, Manmohan Singhal

Subjects: Get full text

Antiparkinsonian effect of Nutmeg ethanolic extract (Myristica fragrans Houtt.) in haloperidol-induced Mice by Dwi Hadi Setya Palupi, Isma Galuh Fekhayanti

Subjects: Get full text

Disulfide bridge-targeted metabolome mining unravels an antiparkinsonian peptide by Zhiwu Tong, Xiahong Xie, Huiming Ge, Ruihua Jiao, Tingting Wang, Xincun Wang, Wenying Zhuang, Gang Hu, Renxiang Tan

Subjects: Get full text

Antiparkinsonian activity of new N-methyl-D-aspartate receptor ligands in the arecoline hyperkinesis test by V. D. Dergachev, E. E. Yakovleva, M. A. Brusina, E. R. Bychkov, L. B. Piotrovskiy, P. D. Shabanov

Subjects: Get full text

MANAGEMENT OF PATIENTS WITH PARKINSON’S DISEASE AND AN OVERACTIVE BLADDER by E. S. Korshunova, M. N. Korshunov, S. P. Darenkov

Subjects: Get full text

Impact of Duration of Parkinsonism and Antiparkinsonian Drugs on Coagulation Parameters in Patients with Parkinson’s Disease by Varun Kodam, Sandesh Nanisetty, Sravan K Goud, Rukmini M Kandadai, Surya P Turaga, Shaik A Jabeen, Rupam Borgohain

Subjects: Get full text

Fraternine, a Novel Wasp Peptide, Protects against Motor Impairments in 6-OHDA Model of Parkinsonism by Andréia Mayer Biolchi, Danilo Gustavo Rodrigues de Oliveira, Henrique de Oliveira Amaral, Gabriel Avohay Alves Campos, Jacqueline Coimbra Gonçalves, Adolfo Carlos Barros de Souza, Marcos Robalinho Lima, Luciano Paulino Silva, Márcia Renata Mortari

Subjects: Get full text

Monoaminergic and histaminergic strategies and treatments in brain diseases by Giuseppe Di Giovanni, Dubravka Svob Strac, Montse Sole, Mercedes Unzeta, Keith Francis Tipton, Dorotea Mück-Šeler, Irène Bolea, Laura Della Corte, Matea Nikolac Perkovic, Nela Pivac, Ilse Julia Smolders, Anna Stasiak, Wieslawa Agnieszka Fogel, Philippe De Deurwaerdère

Subjects: Get full text

Drug-induced Parkinson-like events: a real-world study from 2004 to the first quarter of 2024 based on FAERS by Ke Wang, Ke Wang, Junyan Chen, Mingquan Huang, Xinhao Zeng, Xiaoqun Ren, Xiuqiong Liu, Chao Tao, Chao Tao, Liuxuan Yang, Liuxuan Yang, Jinlu Shang, Meiling Zhou

Subjects: Get full text

Drug utilization study of antiparkinsonian medication in Romania during 25 years by Camelia Bucsa, Denisa Bruhs, Anamaria Apan, Elena Francu, Cristina Mogosan, Irina Iaru

Subjects: Get full text

Experimental pharmacokinetics of a new antiparkinsonian drug ADK-1113 by O. Yu. Kravtsova, D. A. Dvoryaninov, G. B. Kolyvanov, A. A. Litvin, O. G. Gribakina, V. P. Zherdev

Subjects: “…antiparkinsonian drug (adk-1113)…”
Get full text

Antiparkinsonian effect of dicholine succinate on the model of MPTP-induced parkinsonism by A. K. Sariev, V. M. Rychikhin, I. A. Pomytkin, T. A. Voronina

Subjects: Get full text